SB 102 (BR 1401) - K. Stein
AN ACT relating to health care services provided in clinical trials for the treatment of cancer.
Create a new section of Subtitle 17A of KRS Chapter 304 to prohibit a health benefit plan from excluding coverage for routine patient healthcare costs that are incurred in the course of a cancer clinical trial if the health benefit plan would provide coverage for the routine patient healthcare cost had it not been incurred in a cancer clinical trial; provide that nothing in this section requires a policy to offer, nor prohibits a policy from offering, cancer clinical trial services by a participating provider; provide that nothing in this section requires services that are performed in a cancer clinical trial by a non-participating provider of a policy to be reimbursed at the same rate as those performed by a participating provider of the policy.
SB 102 - AMENDMENTS
SCA (1, G. Neal) - Amend the exclusion from routine patient healthcare costs to include any treatment outside the usual and customary standard type and frequency of any diagnostic modality and delete any care required to administer or support the service item or investigational drug that is the subject of the clinical trial.
Feb 9-introduced in Senate
Feb 11-to Banking & Insurance (S)
Mar 3-reported favorably, 1st reading, to Consent Calendar with committee amendment (1)
Mar 4-2nd reading, to Rules
Mar 5-recommitted to Appropriations & Revenue (S)
